title: [HIV infection and Lyell syndrome: a wake-up call concerning anti-inflammatory agents].
authors.forename: D A
authors.initials: DA
authors.lastname: de Luis
authors.forename: J
authors.initials: J
authors.lastname: Fortun
authors.forename: V
authors.initials: V
authors.lastname: Pintado
authors.forename: R
authors.initials: R
authors.lastname: Aller de la Fuente
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001228:Aspergillosis / Q000150:complications; D004008:Diclofenac / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000150:complications; D010894:Piroxicam / Q000009:adverse effects*; D011739:Pyrimethamine / Q000009:adverse effects; D013262:Stevens-Johnson Syndrome / Q000209:etiology*; D013411:Sulfadiazine / Q000009:adverse effects; D016781:Toxoplasmosis, Cerebral / Q000150:complications / Q000188:drug therapy
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D013411:Sulfadiazine; D010894:Piroxicam; D004008:Diclofenac; D011739:Pyrimethamine